• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

High frequencies of human genetic diseases: founder effect with genetic drift or selection?

作者信息

Zlotogora J

机构信息

Department of Human Genetics, Hadassah Medical Center, Hebrew University, Jerusalem, Israel.

出版信息

Am J Med Genet. 1994 Jan 1;49(1):10-3. doi: 10.1002/ajmg.1320490104.

DOI:10.1002/ajmg.1320490104
PMID:8172234
Abstract

Rare genetic diseases have been reported with high frequency in some populations. The mechanisms which were proposed to explain most of these observations include founder effect, genetic drift or selective advantage. In recent years, many genes have been sequenced and mutations causing some of these disorders were characterized. According to the analysis of haplotypes and/or mutations, it may be possible to distinguish 3 groups of disorders frequent in isolated populations. In the first group, all the affected patients have only one frequent mutation, suggesting a founder effect with genetic drift. In the second group, more than one mutation is found among the patients; however, most of the patients are homozygotes for one frequent mutation which most probably originated from a common founder; the other patients are compound heterozygotes for the common mutation and a rare mutation. In the third group, more than one frequent mutation is found responsible for each disease. This may be due to a selective advantage which allows the expansion of each new mutation in the particular population or to multiple founder effect with genetic drift in smaller communities which thereafter mixed to form the larger population.

摘要

相似文献

1
High frequencies of human genetic diseases: founder effect with genetic drift or selection?
Am J Med Genet. 1994 Jan 1;49(1):10-3. doi: 10.1002/ajmg.1320490104.
2
Multiple mutations responsible for frequent genetic diseases in isolated populations.多种突变导致孤立人群中常见的遗传疾病。
Eur J Hum Genet. 2007 Mar;15(3):272-8. doi: 10.1038/sj.ejhg.5201760. Epub 2007 Jan 10.
3
Molecular basis of autosomal recessive diseases among the Palestinian Arabs.巴勒斯坦阿拉伯人群常染色体隐性疾病的分子基础。
Am J Med Genet. 2002 May 1;109(3):176-82. doi: 10.1002/ajmg.10328.
4
Models for haplotype evolution in a nonstationary population.非平稳群体中单体型进化的模型。
Theor Popul Biol. 1998 Jun;53(3):184-98. doi: 10.1006/tpbi.1997.1354.
5
An unexpectedly high frequency of heterozygosity for alpha-thalassemia in Ashkenazi Jews.德系犹太人中α地中海贫血杂合子的频率意外偏高。
Blood Cells Mol Dis. 2004 Jul-Aug;33(1):1-3. doi: 10.1016/j.bcmd.2004.04.009.
6
Lower frequency of Gaucher disease carriers among Tay-Sachs disease carriers.在患有泰-萨克斯病的携带者中,戈谢病携带者的比例较低。
Eur J Hum Genet. 1998 Mar-Apr;6(2):185-6. doi: 10.1038/sj.ejhg.5200176.
7
The CHRNE 1293insG founder mutation is a frequent cause of congenital myasthenia in North Africa.CHRNE基因1293insG始创者突变是北非先天性肌无力的常见病因。
Neurology. 2008 Dec 9;71(24):1967-72. doi: 10.1212/01.wnl.0000336921.51639.0b.
8
Founder effect and genetic disease in Sottunga, Finland.芬兰索通加的奠基者效应与遗传疾病。
Am J Phys Anthropol. 1988 Nov;77(3):335-46. doi: 10.1002/ajpa.1330770306.
9
Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer.在患有前列腺癌的加拿大德系犹太人男性中,BRCA1/2基因的始祖突变并不常见。
BMC Med Genet. 2003 Aug 11;4:7. doi: 10.1186/1471-2350-4-7.
10
Hereditary disorders among Iranian Jews.伊朗犹太人中的遗传性疾病。
Am J Med Genet. 1995 Jul 31;58(1):32-7. doi: 10.1002/ajmg.1320580108.

引用本文的文献

1
Tribal Founder Variant in 5 Kuwaiti Families Expands Phenotypic Spectrum of -Related Disorder.5个科威特家庭中的部落奠基者变异扩大了与-相关疾病的表型谱。
Neurol Genet. 2024 May 22;10(3):e200156. doi: 10.1212/NXG.0000000000200156. eCollection 2024 Jun.
2
Origin and Spread of the ALDH2 Glu504Lys Allele.乙醛脱氢酶2(ALDH2)Glu504Lys等位基因的起源与传播
Phenomics. 2021 Sep 20;1(5):222-228. doi: 10.1007/s43657-021-00017-y. eCollection 2021 Oct.
3
Prevalence and founder effect of DRC1 exon 1-4 deletion in Korean patients with primary ciliary dyskinesia.
DRC1 外显子 1-4 缺失在韩国原发性纤毛运动障碍患者中的患病率及起源效应。
J Hum Genet. 2023 Jun;68(6):369-374. doi: 10.1038/s10038-023-01122-8. Epub 2023 Feb 7.
4
Genetic Characteristics and Variation Spectrum of USH2A-Related Retinitis Pigmentosa and Usher Syndrome.USH2A相关视网膜色素变性和Usher综合征的遗传特征及变异谱
Front Genet. 2022 Aug 30;13:900548. doi: 10.3389/fgene.2022.900548. eCollection 2022.
5
Systematic estimation of cystic fibrosis prevalence in Chinese and genetic spectrum comparison to Caucasians.系统评估中国人囊性纤维化的患病率,并与高加索人进行遗传谱比较。
Orphanet J Rare Dis. 2022 Mar 21;17(1):129. doi: 10.1186/s13023-022-02279-9.
6
Neuroprotective effects respond to cerebral ischemia without susceptibility to HB-tumorigenesis in VHL heterozygous knockout mice.在VHL杂合敲除小鼠中,神经保护作用对脑缺血有反应,且不易发生HB肿瘤形成。
Mol Carcinog. 2017 Oct;56(10):2342-2351. doi: 10.1002/mc.22688. Epub 2017 Jun 30.
7
Clinical neurogenetics: neuropathic lysosomal storage disorders.临床神经遗传学:神经病变性溶酶体贮积症。
Neurol Clin. 2013 Nov;31(4):1051-71. doi: 10.1016/j.ncl.2013.04.007.
8
Founder mutations in Tunisia: implications for diagnosis in North Africa and Middle East.突尼斯的创始突变:对北非和中东诊断的影响。
Orphanet J Rare Dis. 2012 Aug 21;7:52. doi: 10.1186/1750-1172-7-52.
9
Complex cellular functions of the von Hippel-Lindau tumor suppressor gene: insights from model organisms.von Hippel-Lindau 肿瘤抑制基因的复杂细胞功能:来自模式生物的见解。
Oncogene. 2012 May 3;31(18):2247-57. doi: 10.1038/onc.2011.442. Epub 2011 Sep 26.
10
Linkage disequilibrium mapping in the Newfoundland population: a re-evaluation of the refinement of the Bardet-Biedl syndrome 1 critical interval.纽芬兰人群中的连锁不平衡定位:对巴德-比埃尔综合征1关键区间精细定位的重新评估。
Hum Genet. 2005 Jan;116(1-2):62-71. doi: 10.1007/s00439-004-1184-9. Epub 2004 Oct 23.